Fatty acid ethyl esters: Toxic non-oxidative metabolites of ethanol and markers of ethanol intake

Frontiers in Bioscience

Volumn 8, Issue , 2003, Pages

  Best, Catherine A ^a   Laposata, Michael ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alcohol; Biomarker; Ethanol; FAEE; Fatty Acid Ethyl Esters; Review

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; FATTY ACID ESTER; SYNTHETASE;

ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOL OXIDATION; ALCOHOLISM; CELL TRANSPORT; CYTOTOXICITY; DEGRADATION; DRINKING BEHAVIOR; ESTERIFICATION; GAS CHROMATOGRAPHY; HUMAN; HYDROLYSIS; MASS SPECTROMETER; REVIEW; SEX DIFFERENCE;

EID: 3142681708     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Ninth Special Report to the US Congress on Alcohol and Health. U.S. Department of Health and Human Services National Institute on Alcohol Abuse and Alcoholism, 131-192 (1997)
2. Grant B, T.C. Harford, D.A. Dawson, P. Chou, M. Dufour & R. Pickering: Prevalence of DSM-IV alcohol abuse and dependence, United States 1992. Alcohol Health Res World 18, 243-248 (1994)
3. th Special Report to the U.S. Congress on Alcohol and Health. NIH Pub No.00-1583. Bethesda, MD: The Institute, (2000)
4. Rice D.P: Economic Costs of Substance Abuse, 1995. Proc Assoc Am Physicians 111,119-125 (1999)
5. McGinnis J.M., W.H. Foege: Mortality and morbidity attributable to the use of addictive substances in the United States. Proc Assoc Am Physicians 111, 109-118 (1999)
6. th ed. Washington DC: American Psychiatric Association, 175-273 (1994)
7. Lieber C.S: Medical disorders of alcoholism. N Engl J Med 333, 1058-1065 (1995)
8. Julien R.M: A primer to drug action Eds: W.H. Freeman and Company, New York, 71-92 (1992)
9. th edition. Lippincott Williams and Wilkins, 1289-1316 (2000)
10. Zakhari S: Alcohol and the Cardiovascular System. Molecular Mechanisms for Beneficial and Harmful Action. Alcohol Health and Research World 21, 21-29 (1997)
11. Berman M.O., B. Shagrin, D.L. Evert, & C. Epstein: Impairments of Brain and Behavior. The Neurological Effects of Alcohol. Alcohol Health and Res World 21, 65-75 (1997)
12. Abel E.K. & R.J. Sokol: Incidence of fetal alcohol syndrome and economic impact of FAS-related anomalies. Drug Alcohol Depend 19, 51-70 (1987)
13. Wu, A.H.B: Pharmacokinetic aspects of ethanol for medicolegal purposes. Am Assoc Clin Chem Briefing 12, 5-13 (1991)
14. Baraona E., C.S. Abittan, K. Dohman, M. Moretti, G. Pozzato, Z.W. Chayes, C. Schaefer & C.S. Lieber: Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res 25 502-507 (2001)
15. Seitz H.K., G. Egerer, U.A. Simanowski, R. Waldherr, R. Eckey, D.P. Agarwal, H.W. Goedde & J-P Von Wartburg: Human gastric alcohol dehydrogenase activity: effect of age, sex and alcoholism. Gut 34, 1433-1437 (1993)
16. Lieber C.S: Ethanol metabolism, cirrhosis and alcoholism. Clin Chim Acta 257, 59-84 (1997)
17. Tuyns A.J. & G. Pequignot: greater risk of ascitic cirrhosis in females in relation to alcohol consumption. Int J Epidemiol 13, 53-57 (1984)
18. Clothier J., J.T. Kelly, K. Reed & E.L. Reilly: Varying rates of alcohol metabolism in relation to detoxification medication. Alcohol 2, 443-445 (1985).
19. Wilkinson P.K: Pharmacokinetics of ethanol. Alcohol Clin Exp Res 4, 6-21 (1980)
20. Riveros-Rosas H., A. Julian-Sanchez & E. Pina: Enzymology of ethanol and acetaldehyde metabolism in mammals. Arch Med Res 28, 453-471 (1997)
21. Keilin D. & E.F. Hartree: Properties of catalase: Catalysis of coupled oxidation of alcohols. Biochem J 39, 293-301 (1945)
22. Moser H.W., & A.B. Moser: Long chain fatty acids and peroxisomal disorders. In: Polyunsaturated fatty acid in human nutrition. Eds: Bracco U., R.J. Deckelbaum, Nestec Vevey/Raven Press, New York, 65-79 (1992)
23. Laposata M: Assessment of ethanol intake current tests and new assays on the horizon. Am J Clin Pathol 112, 443-450 (1999)
24. Werner J., S. Mouris, A.L. Warshaw, K.B. Lewandrowski, M. Laposata, R.V. Iozzo, E.A. Carter, R.J. Schatz & C. F. Castillo: Alcoholic pancreatitis in rats: injury from nonoxidative metabolites of ethanol. Am J Physiol Gastrointest Liver Physiol 283, G65-G73 (2002)
25. Beisswenger T.B., B. Holmquist & B.L. Valle: Proc. Natl. Acad. Sci 82, 8369-8373 (1985)
26. Eriksson C.J. P. & H. W. Sipple: Biochem. Pharmacol 26, 241-247 (1977)
27. Laposata E.A. & L.G. Lange: Presence of non-oxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 231, 497-499 (1986)
28. Calabrese V., A. Calderone, N. Ragusa & V. Rizza: Effects of metadoxine on cellular formation of fatty acid ethyl esters in ethanol treated rats. Int J Tiss Reac XVII, 101-108 (1995)
29. Laposata M: Fatty acid ethyl esters: ethanol metabolites which mediate ethanol-induced organ damage and serve as markers of ethanol intake. Prog Lipid Res 37, 307-316 (1998)
30. Newsome W.H. & J.B.M. Rattray: The enzymatic esterification of ethanol with fatty acids. Can J Biochem 43, 1223-1233 (1965)
31. Mogelson S. & L.G. Lange: Non-oxidative ethanol metabolism in rabbit myocardium: purification to homogeneity of fatty acyl ethyl ester synthase. Biochemistry 23, 4075-4081 (1984)
32. Laposata E.A., D.E. Scherrer, C. Mazow & L. Lange: Metabolism of ethanol by human brain to fatty acid ethyl esters. J Biol Chem 262, 4653-4657 (1987)
33. Bora P.S., C.A. Spilburg & L.G. Lange: Purification to homogeneity and characterization of major fatty acid ethyl ester synthase from human myocardium. FEBS Letters 285, 236-239 (1989)
34. Treloar T., L.J. Madden, J.S.Winter, J.L. Smith & J. de Jersey: Fatty acid ethyl ester synthesis by human liver microsomes. Biochim Biophys Acta 1299, 160-166 (1996)
35. Lange L.G: Mechanism of fatty acid ethyl ester formation and biological significance. Ann NY Acad Sci 625, 802-806 (1991)
36. Sharma R., S. Gupta, S.S. Singhal, H. Ahmad, A. Haque & Y.C. Awasthi: Independent segregation of glutathione S-transferase and fatty acid ethyl ester synthase from pancreas and other human tissues. Biochem J 275, 507-513 (1991)
37. Board P., S. Smith, J. Green, M. Coggan & T. Suzuki: Evidence against a relationship between fatty acid ethyl ester synthase and the pi class glutathione S-transferase in humans. J Biol Chem 268, 15655-15658 (1993)
38. Riley D.J.S., E.M. Kyger, C.A. Spilburg & L.G. Lange: Pancreatic cholesterol esterases: purification and characterization of human pancreatic fatty acid ethyl ester synthase. Biochemistry 29, 3848-3852 (1990)
39. Dan L., J. E. Cluette-Brown, A. Kabakibi & M. Laposata: Quantitation of the mass of fatty acid ethyl esters synthesized by HepG2 Cells incubated with ethanol. Alcoholism Clin Exp Res 22, 1125-1131 (1998)
40. Kaphalia B.S. & G.A.S. Ansari: Fatty acid ethyl esters and ethanol-induced pancreatitis. Cell Mol Biol 47, OL173-OL179 (2001)
41. Heith A.M., C.R. Morse, T. Tsujita, S.A.Volpacelli, J.G. Flood & M. Laposata: Fatty acid ethyl ester synthase catalyzes the esterification of ethanol to cocaine. Biochern Biophys Res Commun 208, 549-554 (1995)
42. Diczfalusy M.A., I. Bjorkhem, C. Einarsson & S.E.H. Alexson: Formation of fatty acid ethyl esters in rat liver microsomes. Evidence for a key role for acyl-CoA : ethanol O-acyltransferase. Eur J Biochem 259, 404-411 (1999)
43. Diczfalusy M.A., I. Bjorkhem, C. Einarsson, C. Hillebrant & S.E.H. Alexson: Characterization of enzymes involved in formation of ethyl esters of long-chain fatty acids in humans. J Lipid Res 42, 1025-1032 (2001)
44. Tsujita T. & H. Okuda: Fatty acid ethyl ester-synthesizing activity of lipoprotein lipase from rat post heparin plasma. J Biol Chem 269, 5884-5889 (1994)
45. Riley D.J., E.M. Kyger & C.A. Spilburg: Pancreatic cholesterol esterases. II. Purification and characterization of human pancreatic fatty acid ethyl ester synthase. Biochemistry 29, 3848-3852 (1992)
46. Lange L.G: Nonoxidative ethanol metabolism: formation of fatty acid ethyl esters by cholesterol esterase. Proc Natl Acad Sci USA 79, 3954-3957 (1982)
47. Tsujita T. & H. Okuda: Fatty acid ethyl ester synthase in rat adipose tissue and its relationship to carboxylesterase. J Biol Chem 267, 23489-23494 (1992)
48. Tsujita T. & H. Okuda: The synthesis of fatty acid ethyl ester by carboxylesterase lipase. Eur J Biochem 224, 57-62 (1994)
49. Chang W., C. Waltenbaugh & J. Borensztajn: Fatty acid ethyl ester synthesis by the isolated perfused rat heart. Metabolism 46, 926-929 (1997)
50. Gorski N.P., H. Nouraldin, D. Dube, F.I. Preffer, D.M. Dombkowski, E. Villa, K.B. Lewandrowski, R.D. Weiss, C. Hufford & M. Laposata: Reduced FAEE synthase activity in the white blood cells of alcoholics. Alcohol Clin Exp Res 20, 268-274 (1996)
51. Aleryani S., A. Kabakibi, J.E. Cluette-Brown & M.Laposata: Fatty acid ethyl ester synthase, an enzyme for non-oxidative ethanol metabolism, is present in serum after liver and pancreatic injury. Clin Chem 42, 24-27 (1996)
52. Hungund B. L., Z. Zheng & A.I. Barkai: Turnover of ethyl-linoleate in rat plasma and its distribution in various organs. Alcohol Clin Exp Res 19, 374-377 (1995)
53. Saghir M., J. Werner & M. Laposata: The rapid and extensive hydrolysis of fatty acid ethyl esters, toxic non-oxidative ethanol metabolites, in the gastrointestinal tract and circulation of rats. Am J Physiol (Gastrointest Liver Physiol 36) 273, G I 84-G 190 (1997)
54. Saghir M., E. Blodget & M. Laposata: The hydrolysis of fatty acid ethyl esters in low-density lipoproteins by red blood cells, white blood cells and platelets. Alcohol 19, 163-168 (1999)
55. Szczepiorkowski Z.M., G.R. Dickerson & M. Laposata: Fatty acid ethyl esters decrease human hepatoblastoma cell proliferation and protein synthesis. Gastroenterology 108, 515-522 (1995)
56. Laposata E.A., E.H. Harrison & E.B. Hedberg: Synthesis and degradation of fatty acid ethyl esters by cultured hepatoma cells exposed to ethanol. J Biol Chem 265, 9688-9693 (1990)
57. Lange L.G. & B.E. Sobel: Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol. J Clin Invest 72, 724-731 (1983)
58. Kabakibi A., R.C. Morse & M. Laposata: Fatty acid ethyl esters and HepG2 cells Intracellular synthesis and release from the cells. J Lipid Res 39,1568-1582 (1998)
59. Doyle K.M., D.A. Bird, S. Al-salihi, Y. Hallaq, J.E. Cluette-Brown, K. A. Goss & M. Laposata: Fatty acid ethyl esters are present in human serum after ethanol ingestion. J Lipid Res 35, 428-437 (1994)
60. Bird D.A., A. Kabakibi & M. Laposata: The distribution of fatty acid ethyl esters among lipoproteins and albumin in human serum. Alcohol Clin Exp Res 21, 602-605 (1997)
61. 13C NMR study J Lipid Res 37, 1449-1458 (1996)
62. Hasaba A. & M. Laposata: The synthesis and secretion of fatty acid ethyl esters from HepG2 cells are stimulated by lipoproteins and albumin. Alcohol Clin Exp Res 25, 338-343 (2001)
63. Werner J., M. Laposata, F.C. Castillo, M. Saghir, R.V. Iozzo, K.B. Lewandrowski & A.L. Warshaw: Pancreatic injury induced by fatty acid ethyl ester, a non-oxidative metabolite of alcohol. Gastroenterolgy. 113, 286-94 (1997)
64. Haber P.S., J.S.Wilson, M.V. Apte & R.C. Pirola: Fatty acid ethyl esters increase rat pancreatic lysosomal fragility. J Lab Clin Med 121, 759-764, (1993)
65. Ponnappa B.C., J.S. Ellingson, J.B. Hoek & E. Rubin: Intracellular accumulation of fatty acid ethyl esters inhibits pancreatic protein synthesis. Gastroenterology 106, 316 A (1994)
66. Bora P.S., M.A. Farrar, D.D. Miller, B.R. Chaitman & B.L. Guruge: Myocardial cell damage by fatty acid ethyl esters. J Cardiovasc Pharm. 27, 1-6 (1996)
67. Lange L.G. & B.E. Sobel: Fatty acid ethyl esters and heart disease. Alcohol Health Res World 14, 285-287 (1990)
68. Hungund B.L., D.B. Goldstein, F. Villegas & T.B. Cooper: Formation of fatty acid ethyl esters during chronic ethanol treatment in mice. J Chem Pharmacol 37, 3001-3004 (1988)
69. Gubitosi-Klug R.A. & R.W. Gross: Fatty acid ethyl esters, non-oxidative metabolites of ethanol, accelerate the kinetics of activation of the human brain delayed rectifier K+ channel, Kv I. I. J Biol Chem 271, 519-522 (1996)
70. Bearer C.F., S. Gould, R. Emerson & P. Kinnunen: Fetal alcohol syndrome and fatty acid ethyl esters. Pediatr Res 31, 492-495 (1992)
71. Hungund D.L. & B. Gokhale: Reduction of fatty acid ethyl ester accumulation by ganglioside GM 1 in rat fetus exposed to ethanol. Biochem Pharmacol 48, 2103-2108 (1994)
72. Bearer C.F., S.Lee, A.E. Salvator, S. Minnes, A. Swick, T. Yamashita & L.T. Singer: Ethyl linoleate in meconium a biomarker for prenatal ethanol exposure. Alcoholism Clin Exp Res 23, 487-493 (1999)
73. Klein J., T. Karaskov & G. Koren: Fatty acid ethyl esters a novel biologic marker for heavy in utero ethanol exposure: a case report. Ther Drug Monitor 21, 644-646 (1999)
74. Oslin D.W., H.M. Pettinati, G. Luck, A. Semwanga, A. Cnaan & C.P. O'Brien: Clinical correlations with carbohydrate-deficient transferrin levels in women with alcoholism. Alcohol Clin Exp Res 22,1981-1985 (1998)
75. Bean P., K. Liegmann, T. Løvli, C. Westby & E. Sundrehagen: Semiautomated procedures for evaluation of carbohydrate-deficient transferring in the diagnosis of alcohol abuse. Clin Chem 43, 983-989 (1997)
76. Laposata M: Fatty acid ethyl esters: ethanol metabolites which mediate ethanol-induced organ damage and serve as markers of ethanol intake. Prog Lipid Res 37, 307-316 (1998)
77. Doyle K.M., J.E. Cluette-Brown, D. Dube, T. Bernhardt, C.R. Morse & M. Laposata: Fatty acid ethyl esters in the blood as markers for ethanol intake. JAMA 276, 1152-1156 (1996)
78. Soderberg B.L., E.T. Sicinska, E. Blodget, J.E. Cluette-Brown, P.M. Suter, T. Schuppisser & M. Laposata: Preanalytical variables affecting the quantitation of fatty acid ethyl esters in plasma and serum samples. Clin Chem 45, 2183-2190 (1999)
79. Pollock D.A., C.A. Boyle, F. DeStefano, L.A. Moyer & M.L. Kirk: Underreporting of alcohol-related mortality on death certificates of young US army veterans. JAMA 258, 345-348 (1987)
80. Laposata M: Assessment of ethanol intake current tests and new assays on the horizon. Am J Clin Pathol 112, 443 -450 (1999)
81. Laposata E. A., D.E. Scherrer & L.G. Lange: Fatty acid ethyl esters in adipose tissue. A laboratory marker for alcohol-related death. Arch Pathol Lab Med 113, 762-766 (1989)
82. Refaai M. A., P.N. Nguyen, T. Steffensen, R.J. Evans, J.E. Cluette-Brown & M. Laposata: Liver and adipose tissue fatty acid ethyl esters obtained at autopsy are postmortem markers for premortem ethanol intake. Clin Chem 48, 77-83 (2002)
83. Soderberg B.L., E.T Sicinska, C.A. Best, J.E. Cluette-Brown & M. Laposata: The diagnosis of chronic alcoholism by fatty acid composition of fatty acid ethyl esters (abstract) Alcohol Clin Exp Res 25, 136 A (2001)
84. Pita M., J. Rubio, M. Murillo, O. Carreras & M. Delgado: Chronic alcoholism decreases polyunsaturated fatty acid levels in human plasma, erythrocytes and platelets-influence of chronic liver disease. Thromb Haemost 78, 808-812 (1997)
85. Abel E.K. & R.J. Sokol: Incidence of fetal alcohol syndrome and economic impact of FAS-related anomalies. Drug Alcohol Depend 19, 51-70 (1987)
86. Streissguth A.P., H.M. Barr, J. Kogan & F.L. Bookstein: Understanding the occurrence of secondary disabilities in clients with fetal alcohol syndrome (FAS) and fetal alcohol effects (FAE). Final Report. University of Washington School of Medicine, Department of Psychiatry and behavioral Sciences, Seattle, WA. (1996)
87. Sachs H., & P. Kintz: Testing for drugs in hair. Critical review of chromatographic procedures since 1992. J Chromatography 713, 147-161 (1998)
88. Pragst F., V. Auwaerter, F. Sporkert & K. Spiegel: Analysis of fatty acid ethyl esters in hair as possible markers of chronically elevated alcohol consumption by headspace solid phase microextraction (HS-SPME) and gas chromatography-mass spectrometry (GC-MS). For Sci Int 121, 76-88 (2001)
89. Auwärter V., F. Sporkert, S. Hartwig, F. Pragst, V. Hannelore & A. Diefenbacher: Fatty acid ethyl esters in hair as markers of alcohol consumption. Segmental hair analysis of alcoholics, social drinkers and teetotalers. Clin Chem 47, 2114-2123 (2001)
90. Kaluzny M.A., L.A. Duncan, M.V. Merrit & D.E. Epps: Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res 26, 135-140 (1985)
91. Bernhardt T.G., P.A. Cannistraro, D.A. Bird, K.M. Doyle & M. Laposata: Purification of fatty acid ethyl esters by solid phase extraction and high performance liquid chromatography. J Chromatogr B 675, 189-1996 (1996)
92. Zybko W. C., J. E. Cluette-Brown & M. Laposata: Improved sensitivity and reduced sample size in serum fatty acid ethyl ester analysis. Clin Chem 47, 1120-1121 (2001)
93. Laposata M., Z.M. Szczepiorkowski & J.E. Cluette-Brown: Fatty acid ethyl esters: nonoxidative metabolites of ethanol. Prostaglandins Leukot Essent Fatty Acids 52, 87-91 (1995)
94. Lange L.G., S.R. Bergman & B.E. Sobel: Identification of fatty acid ethyl esters as products of rabbit myocardial ethanol metabolism. J Biol Chem 256, 12968-12973 (1981)
95. Kaphalia B.S., J.B.Carr & G.A.S Ansari: Increased endobiotic fatty acid methyl esters following exposure to methanol. Fundam Appl Toxicol 28, 264-273 (1995)
96. Salem R. O., J.E. Cluette-Brown, A. Hasaba & M. Laposata: Effect of specimen anticoagulant and storage on measurement of serum and plasma fatty acid ethyl esters concentrations. Clin Chem 47, 126-127 (2001)
97. Calam D.H: Natural occurrence of fatty acid ethyl esters [letter]. Science 174, 78 (1971)
98. Laseter J.L. & J.D. Weete: Fatty acid ethyl esters of Rhizopus arrhizus. Science 172, 864-865 (1971)
99. Calam D.H: Species and sex specific compounds from the heads of male bummblebees. Nature 221, 856-857 (1969)
100. Ikan R., E.D. Bergmann, U. Yinon & A. Shulov: Identification synthesis & biological activity of an "assembling scent" from the beetle trogoderma granarium. Nature 223, 317 (1969)
101. Goss K.A., R. Alharethi & M. Laposata: Fatty acid ethyl ester synthesis in the preparation of scotch whiskey. Alcohol 17, 241-245 (1999)
102. Gallart M., F. Sonia, A. Viu-Marco, E. Lopez-Tamames & S. Buxaderas: Determination of free fatty acids and their ethyl esters in musts and wines. J Chromatogr A 776, 283-291 (1997)
103. Nordoy A., L. Barstad, W.E. Connor & L. Hatcher: Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans. Am J Clin Nutr 53, 1185-1190 (1991)